PhaseBio Pharmaceuticals Analysis

PhaseBio Pink Sheet Analysis Notes

About 25.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Phasebio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 60 people.The quote for PhaseBio Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about PhaseBio Pharmaceuticals contact Jonathan MBA at 610 981 6500 or learn more at https://phasebio.com.

PhaseBio Pharmaceuticals Investment Alerts

PhaseBio Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PhaseBio Pharmaceuticals's market, we take the total number of its shares issued and multiply it by PhaseBio Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

PhaseBio Pharmaceuticals Outstanding Bonds

PhaseBio Pharmaceuticals Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how PhaseBio Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PhaseBio shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as PhaseBio Pharmaceuticals. By using and applying PhaseBio Pink Sheet analysis, traders can create a robust methodology for identifying PhaseBio entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

If you are still planning to invest in PhaseBio Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseBio Pharmaceuticals' history and understand the potential risks before investing.